FRANCE DOYENNE DE SANTE : revenue, balance sheet and financial ratios

FRANCE DOYENNE DE SANTE is a French company founded 22 years ago, specialized in the sector Location de terrains et d'autres biens immobiliers. Based in PUTEAUX (92800), this company of category GE shows in 2023 a revenue of 978 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - FRANCE DOYENNE DE SANTE (SIREN 449919059)
Indicator 2023 2022 2021 2020 2018 2017 2016
Revenue 978 000 € 151 000 € 589 000 € 589 000 € 589 000 € 4 462 327 € 4 357 037 €
Net income 428 922 € 37 739 € 132 188 € 126 060 € 187 061 € 179 494 € 473 896 €
EBITDA 675 216 € 188 681 € 187 006 € 188 181 € 244 861 € 314 705 € 716 210 €
Net margin 43.9% 25.0% 22.4% 21.4% 31.8% 4.0% 10.9%

Revenue and income statement

In 2023, FRANCE DOYENNE DE SANTE achieves revenue of 978 k€. Revenue is declining over the period 2016-2023 (CAGR: -19.2%). Vs 2022, growth of +548% (151 k€ -> 978 k€). After deducting consumption (0 €), gross margin stands at 978 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 675 k€, representing 69.0% of revenue. Warning negative scissor effect: despite revenue change (+548%), EBITDA varies by +258%, reducing margin by 55.9 pts. This reflects costs rising faster than revenue. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 429 k€, i.e. 43.9% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2023) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

978 000 €

Gross margin (2023) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

978 000 €

EBITDA (2023) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

675 216 €

EBIT (2023) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

656 061 €

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

428 922 €

EBITDA margin (2023) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

69.0%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 61%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Cash flow represents 58.5% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.0%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

61.093%

Cash flow / Revenue (2023) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

58.511%

Repayment capacity (2023) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.0

Solvency indicators evolution
FRANCE DOYENNE DE SANTE

Sector positioning

Debt ratio
0.0 2023
2021
2022
2023
Q1: -25.79
Med: 7.7
Q3: 166.03
Good +16 pts over 3 years

In 2023, the debt ratio of FRANCE DOYENNE DE SANTE (0.00) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
61.09% 2023
2021
2022
2023
Q1: 0.43%
Med: 30.83%
Q3: 76.17%
Good +29 pts over 3 years

In 2023, the financial autonomy of FRANCE DOYENNE DE SANTE (61.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
0.0 years 2023
2021
2022
2023
Q1: -0.3 years
Med: 0.44 years
Q3: 10.35 years
Good +10 pts over 3 years

In 2023, the repayment capacity of FRANCE DOYENNE DE SANTE (0.00) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 254.65. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 3.5x. Financial charges are adequately covered by operations.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

254.651

Interest coverage (2023) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

3.523

Liquidity indicators evolution
FRANCE DOYENNE DE SANTE

Sector positioning

Liquidity ratio
254.65 2023
2021
2022
2023
Q1: 95.03
Med: 298.23
Q3: 1220.9
Average +15 pts over 3 years

In 2023, the liquidity ratio of FRANCE DOYENNE DE SANTE (254.65) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
3.52x 2023
2021
2022
2023
Q1: 0.0x
Med: 0.0x
Q3: 16.99x
Good -20 pts over 3 years

In 2023, the interest coverage of FRANCE DOYENNE DE SANTE (3.5x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 186 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 0 days. The gap of 186 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Overall, WCR represents 490 days of revenue, i.e. 1.3 M€ to permanently finance. Over 2016-2023, WCR increased by +603%, requiring additional financing.

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

1 331 029 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

186 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2023) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

490 j

WCR and payment terms evolution
FRANCE DOYENNE DE SANTE

Positioning of FRANCE DOYENNE DE SANTE in its sector

Comparison with sector Location de terrains et d'autres biens immobiliers

Valuation estimate

Based on 215 transactions of similar company sales in 2023, the value of FRANCE DOYENNE DE SANTE is estimated at 2 376 206 € (range 687 972€ - 4 079 982€). With an EBITDA of 675 216€, the sector multiple of 5.2x is applied. The price/revenue ratio is 0.51x (in line with sector norms). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2023
215 transactions
687k€ 2376k€ 4079k€
2 376 206 € Range: 687 972€ - 4 079 982€
NAF 5 année 2023

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
675 216 € × 5.2x
Estimation 3 479 755 €
882 853€ - 5 591 382€
Revenue Multiple 30%
978 000 € × 0.51x
Estimation 499 383 €
227 391€ - 1 142 444€
Net Income Multiple 20%
428 922 € × 5.7x
Estimation 2 432 566 €
891 641€ - 4 707 791€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Location de terrains et d'autres biens immobiliers)

Compare FRANCE DOYENNE DE SANTE with other companies in the same sector:

Voir toutes les statistiques du secteur Location de terrains et d'autres biens immobiliers

Frequently asked questions about FRANCE DOYENNE DE SANTE

What is the revenue of FRANCE DOYENNE DE SANTE ?

The revenue of FRANCE DOYENNE DE SANTE in 2023 is 978 k€.

Is FRANCE DOYENNE DE SANTE profitable?

Yes, FRANCE DOYENNE DE SANTE generated a net profit of 429 k€ in 2023.

Where is the headquarters of FRANCE DOYENNE DE SANTE ?

The headquarters of FRANCE DOYENNE DE SANTE is located in PUTEAUX (92800), in the department Hauts-de-Seine.

Where to find the tax return of FRANCE DOYENNE DE SANTE ?

The tax return of FRANCE DOYENNE DE SANTE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does FRANCE DOYENNE DE SANTE operate?

FRANCE DOYENNE DE SANTE operates in the sector Location de terrains et d'autres biens immobiliers (NAF code 68.20B). See the 'Sector positioning' section above to compare the company with its competitors.